AtriCure, Inc.
NASDAQ:ATRCMedical - Instruments & Supplies
+$0.96 today
- Market cap
- $2.82B
- Beta
- 1.26
- P/E (TTM)
- -295.5
- EPS (TTM)
- -$0.10
Volume 0.60M
Average 0.77M
ATRC Total Current Liabilities
All obligations due within one year.
AtriCure, Inc.NASDAQ: ATRC
Total Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total current liabilities rises 19.0% from a year ago
Total current liabilities stood at $81.92M at the end of Q2 FY2026, up 19.0% from a year earlier and up 11.9% from the prior quarter. Over 3 fiscal years it compounded at +11.8% a year.
Context
- Total current liabilities amounted to 12.1% of total assets at the end of Q2 FY2026, up 0.8 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +19.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 81.52M USD
- Year-over-year change
- +11.0%
- 4-year CAGR
- +9.6%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 81.52M | +11.0% |
| FY2024 | 2024-12-31 | 73.42M | -1.5% |
| FY2023 | 2023-12-31 | 74.57M | +27.7% |
| FY2022 | 2022-12-31 | 58.39M | +3.4% |
| FY2021 | 2021-12-31 | 56.45M | — |
Total Current Liabilities vs competitors
How ATRC compares with its peers on the latest reported figures
- ATRC's Jun 2026 total current liabilities of $81.92M is the lowest of the 5 companies compared; the peer median is $3.97B.
- Its year-over-year change of +19.0% is the 2nd highest of 5, against a peer median of +4.8%.
- Total current liabilities amounts to 12.1% of total assets for ATRC, versus a peer median of 13.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jul 2026 | $11.8B | +2.3% | +8.8% | 12.6% | |
| Jun 2026 | $6.43B | +23.9% | +12.7% | 14.2% | |
| Jun 2026 | $1.51B | +7.3% | +21.1% | 10.9% | |
| Sep 2026 | $740.2M | -10.6% | +39.5% | 27.3% | |
| Jun 2026 | $81.92M | +19.0% | +11.8% | 12.1% | |
| Peer median (excluding ATRC) | $3.97B | +4.8% | +16.9% | 13.4% | |
Competitors are the stored peer set for ATRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 43.65M | 58.1M | 84.31M | 122.72M | 167.43M |
| Short-term Investments | 75.44M | 63.01M | 52.98M | 0 | 0 |
| Net Receivables | 33.02M | 42.69M | 52.5M | 60.34M | 66.65M |
| Inventory | 38.96M | 45.93M | 67.9M | 75.34M | 78.49M |
| Other Current Assets | 0 | 0 | 8.56M | 9.43M | 9.94M |
| Total Current Assets | 196.08M | 215.21M | 266.25M | 267.83M | 322.52M |
| Property, Plant & Equipment (Net) | 36.17M | 42.62M | 46.76M | 47.39M | 45.99M |
| Goodwill | 234.78M | 234.78M | 234.78M | 234.78M | 234.78M |
| Intangible Assets | 42.99M | 39.34M | 63.99M | 56.47M | 48.03M |
| Long-term Investments | 104.34M | 51.51M | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 955K | 1.99M | 2.16M | 2.87M | 2.86M |
| Total Non-current Assets | 419.24M | 370.23M | 347.69M | 341.5M | 331.66M |
| Total Assets | 615.31M | 585.45M | 613.93M | 609.33M | 654.18M |
| Account Payables | 18.6M | 19.9M | 27.35M | 25.03M | 78.4M |
| Short-term Debt | 0 | 3.33M | 2.53M | 2.81M | 3.12M |
| Tax Payables | 1.45M | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 33.41M | 2.8M | 2.75M | 42.63M | 0 |
| Total Current Liabilities | 56.45M | 58.39M | 74.57M | 73.42M | 81.52M |
| Long-term Debt | 59.74M | 56.83M | 60.59M | 61.87M | 73.38M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.22M | 1.23M | 1.23M | 1.21M | (4.17M) |
| Total Non-current Liabilities | 75.11M | 70.3M | 73.2M | 74.94M | 80.72M |
| Total Liabilities | 131.56M | 128.69M | 147.76M | 148.36M | 162.24M |
| Common Stock | 46K | 47K | 48K | 49K | 50K |
| Retained Earnings | (280.15M) | (326.62M) | (357.06M) | (401.76M) | (413.2M) |
| Accumulated OCI | (948K) | (4.1M) | (993K) | (1.04M) | 566K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 483.76M | 456.75M | 466.17M | 460.97M | 491.94M |
| Total Debt | 75.65M | 74.55M | 74.49M | 76.53M | 88.02M |
| Net Debt | 31.99M | 16.45M | (9.82M) | (46.19M) | (79.41M) |
AtriCure, Inc.
NASDAQ:ATRC
Intrinsic Alpha fair value
Locked
Current Price
$55.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.